Mercury Drug v. De Leon
REITERATIONFacts
The Antecedents: Respondent Raul T. De Leon, a Regional Trial Court judge, experienced an irritated left eye and difficulty reading. He consulted a doctor friend who prescribed "Cortisporin Opthalmic" and "Ceftin." De Leon purchased the prescribed medicines from a Mercury Drug Store branch, presenting the prescription to petitioner Aurmela Ganzon, a pharmacist assistant. After applying the dispensed medication, De Leon experienced searing pain, discovering he had been given "Cortisporin Otic Solution" (ear drops) instead of the prescribed eye drops. He confronted Ganzon, who admitted she could not read the prescription clearly. The supervisor later informed De Leon that the store did not have "Cortisporin Opthalmic" in stock. De Leon's subsequent written request for an apology and explanation to Mercury Drug went unanswered, prompting him to file a complaint for damages. Procedural History: The Regional Trial Court (RTC) ruled in favor of De Leon, awarding him pecuniary loss for the medicine, moral damages, exemplary damages, and attorney's fees. The RTC found Ganzon negligent in dispensing the wrong medication and held Mercury Drug liable for its employee's actions. Dissatisfied, Mercury Drug and Ganzon appealed to the Court of Appeals (CA). The CA, however, granted De Leon's motion to dismiss the appeal, citing the petitioners' failure to make page references to the record in their brief, as required by the Rules of Civil Procedure. The CA subsequently denied their motion for reconsideration. The Petition: Petitioners Mercury Drug Corporation and Aurmela Ganzon filed a petition for review on certiorari with the Supreme Court, arguing that the CA committed grave abuse of discretion in dismissing their appeal based on technicalities. They contended that they had substantially complied with the rules regarding page references in their brief and that the CA should have prioritized substantial justice over mere technicality. The Supreme Court, while acknowledging the procedural lapse, found that the brief provided sufficient information to locate the relevant parts of the record, thus constituting substantial compliance. The Court then proceeded to rule on the merits of the case, affirming the liability of Mercury Drug and Ganzon for their negligence in dispensing the wrong medication, though modifying the awarded damages.
Issue(s)
Whether the Court of Appeals erred in dismissing the petitioners' appeal based on the alleged lack of page references to the records in their appellant's brief, thereby favoring mere technicality over substantial justice, and whether the Court of Appeals committed grave abuse of discretion in dismissing the appeal despite substantial compliance with procedural rules. Whether Mercury Drug Corporation and Aurmela Ganzon were negligent in dispensing the wrong medicine, and the extent of their liability. Whether the award of moral damages was proper and commensurate to the injury. Whether the award of exemplary damages was proper to serve as an example or correction for the public good.
Ruling
The petition is PARTIALLY GRANTED. The Decisions of the CA and the RTC are AFFIRMED WITH MODIFICATION, reducing the award of moral and exemplary damages.
Ratio Decidendi
On the dismissal of the appeal by the Court of Appeals: The Supreme Court held that the dismissal of an appeal under Rule 50 is discretionary and not mandatory. While the absence of page references to the record is a ground for dismissal, it is not a fatal procedural lapse. The Court has held that failure to properly cite references to the original records is not fatal if the citations enable the appellate court to expeditiously locate the portions of the record referred to, constituting substantial compliance. The Court found that the petitioners' brief, despite deficiencies, was sufficient in form and substance to apprise the appellate court of the essential facts, nature of the case, issues, and laws. Therefore, the CA erred in dismissing the appeal solely on this technicality, as rules of procedure are intended to promote substantial justice, not defeat it. On the liability of Mercury Drug and Ganzon for negligence: The Supreme Court affirmed the RTC's finding of negligence. It reiterated that the profession of pharmacy demands the highest degree of care and diligence, citing numerous decisions both local and foreign. Druggists are expected to exercise the highest practicable degree of prudence and vigilance. Mercury Drug and Ganzon failed to exercise this highest degree of diligence when they dispensed ear drops instead of the prescribed eye drops. The Court rejected their defense that they dispensed the only available "Cortisporin Solution" in the market, stating that Ganzon could have verified the medicine or consulted her supervisor, and absent certainty, could have refused the sale. The Court also noted that in cases of employee negligence, a presumption of employer negligence arises, which Mercury Drug failed to rebut. On the award of moral damages: The Court found the award of damages proper but reduced the amounts. Moral damages were reduced from P100,000.00 to P50,000.00. The reduction was based on the peculiar facts of the case and in line with precedent, particularly the case of Mercury Drug Corporation v. Baking. The Court emphasized that while moral damages are not meant to enrich the claimant, they must be commensurate to the loss or injury. On the award of exemplary damages: Exemplary damages were reduced from P300,000.00 to P25,000.00. Exemplary damages were deemed proper to serve as an example or correction for the public good, given the public interest in the drugstore business and the need for meticulousness.
Main Doctrine
Druggists must exercise the highest degree of care and diligence in dispensing medicines, and failure to do so constitutes gross negligence. Procedural lapses in an appeal brief may be overlooked if there is substantial compliance and the court can expeditiously locate the records, prioritizing substantial justice over strict technicality.